title: Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone.
authors.affiliation: Global TB Programme, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland .
authors.forename: Dennis
authors.initials: D
authors.lastname: Falzon
authors.affiliation: Uppsala Monitoring Centre, Uppsala, Sweden .
authors.forename: Geraldine
authors.initials: G
authors.lastname: Hill
authors.affiliation: Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland .
authors.forename: Shanthi N
authors.initials: SN
authors.lastname: Pal
authors.affiliation: National Pharmacovigilance Centre, Bangkok, Thailand .
authors.forename: Wimon
authors.initials: W
authors.lastname: Suwankesawong
authors.affiliation: Global TB Programme, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland .
authors.forename: Ernesto
authors.initials: E
authors.lastname: Jaramillo
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects; D014943:Global Health; D006801:Humans; D060735:Pharmacovigilance; D013828:Thioacetazone / Q000009:adverse effects* / Q000494:pharmacology; D014376:Tuberculosis / Q000188:drug therapy*; D014944:World Health Organization
chemical_list: D000995:Antitubercular Agents; D013828:Thioacetazone